High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
R. Willemze(Radboud University Nijmegen), Théo de Witte(Goethe University Frankfurt), Mario Luppi(University of Modena and Reggio Emilia), Zwi Berneman(University of Antwerp), Paola Fazi(San Antonio College), Liv Meert(Radboud University Nijmegen), Joop H. Jansen(Erasmus University Rotterdam), Daniela Cilloni(University of Turin), Petra Muus(Radboud University Nijmegen), Nicola Cantore(Radboud University Nijmegen), Andrea Camera(Radboud University Nijmegen), Dominik Selleslag(National Institutes of Health), Lorella Melillo(San Antonio College), Francesco Nobile(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Erik W.A. Marijt(Radboud University Nijmegen), Giorgina Specchia(San Antonio College), Martin Mistrík(Radboud University Nijmegen), Giovanna Meloni(Sapienza University of Rome), Simona Sica(San Antonio College), Xavier Thomas(Hôpital Lyon Sud), Marco Vignetti(San Antonio College), Maria Enza Mitra(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Stefan Suciu(Unknown), Meral Beksaç(Ankara University), Sergio Amadori(University of Rome Tor Vergata), Marco Mancini(Radboud University Nijmegen), Dominique Bron, Francesco Fabbiano(San Antonio College), François Lefrère(Hôpital Necker-Enfants Malades), Franco Mandelli(San Antonio College), Pietro Leoni(Azienda Ospedaliero-Universitaria delle Marche), Jean-Pierre Marie(Radboud University Nijmegen), Anne Hagemeijer(Radboud University Nijmegen), Georges Fillet(University of Liège), Silvia Maria Trisolini(Radboud University Nijmegen), Domenico Magro(Radboud University Nijmegen), Boris Labar(Radboud University Nijmegen), José E. Guimarães(Radboud University Nijmegen), Marco Sborgia(Radboud University Nijmegen), Adriano Venditti(University of Rome Tor Vergata), Constantijn J.M. Halkes(Radboud University Nijmegen)
Cited by 168
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k